Israeli Medical Tech Firm Art Medical Enters Receivership Amid Debts

The Central District Court appointed a temporary trustee for Israeli medical tech firm Art Medical after it accumulated $15 million in debts following an FDA regulatory rejection.

Israeli Medical Tech Firm Art Medical Enters Receivership Amid Debts
Photo-illustration WireIsrael: AI Generated

The Central District Court appointed a temporary trustee for the Israeli medical technology firm Art Medical, which has accumulated debts of approximately $15 million following a major regulatory setback. Judge Carmit Ben Eliezer appointed Adv. Eviatar Kramer, head of the insolvency department at the Weksler Bergman law firm, to oversee the proceedings after the official insolvency trustee representative supported the intervention to protect corporate assets, patient safety, and treatment continuity.

Financial Decline and Regulatory Hurdles

Founded in 2008 and based in Netanya, Art Medical develops digital medical devices and specialized nutritional management platforms for intensive care units designed to prevent severe complications such as malnutrition, overfeeding, and ventilation-acquired pneumonia. Over its operational lifespan, the company raised approximately $100 million from prominent backers, including the Bill & Melinda Gates Foundation's Grand Challenges program, a $20 million investment round led by Advanced Medical Technologies LLC, and about $2.6 million in grants from the Israel Innovation Authority. However, the firm faced a critical blow in October 2026 when the United States Food and Drug Administration (FDA) rejected its De Novo regulatory classification request for market clearance, prompting investors to halt funding and leaving the company without cash flow.

Liabilities and Stakeholder Structure

The financial crisis has left Art Medical unable to meet immediate obligations, including unpaid October 2026 salaries totaling roughly 870,000 shekels, about 460,000 shekels in social contributions, and an estimated $1.4 million in employee termination settlements. Additional liabilities comprise roughly 1 million shekels owed to Israeli suppliers, $600,000 to international vendors, and approximately 400,000 shekels in impending tax deductions and national insurance payments. The company's largest single financial obligation is a $10.6 million debt in principal and interest owed to Avanos Medical Inc. stemming from a $9 million convertible loan granted in the summer of 2024, which secured a lien over the company's entire portfolio of roughly 100 registered patents. Despite the crisis, the firm employs 53 workers and maintains distribution agreements with Teva and Italy's MOSS, with products deployed in leading medical centers such as Beilinson Hospital and Hadassah Medical Center. The corporate share registry shows that Rivka Milikovsky, the widow of the late businessman Nathan Milikovsky—a cousin of Prime Minister Benjamin Netanyahu—holds a minor stake of less than one percent, while their daughter Rina Milikovsky serves as a company director alongside founder and shareholder Eli Liron.

Related News